Zacks: Brokerages Expect Encompass Health Co. (NYSE:EHC) Will Announce Quarterly Sales of $1.26 Billion

Wall Street analysts expect that Encompass Health Co. (NYSE:EHC) will report $1.26 billion in sales for the current fiscal quarter, Zacks reports. Five analysts have provided estimates for Encompass Health’s earnings, with estimates ranging from $1.24 billion to $1.28 billion. Encompass Health posted sales of $1.07 billion in the same quarter last year, which would indicate a positive year over year growth rate of 17.8%. The company is scheduled to announce its next earnings report on Monday, July 26th.

On average, analysts expect that Encompass Health will report full-year sales of $5.13 billion for the current year, with estimates ranging from $5.10 billion to $5.18 billion. For the next year, analysts forecast that the business will post sales of $5.53 billion, with estimates ranging from $5.38 billion to $5.59 billion. Zacks’ sales calculations are an average based on a survey of analysts that cover Encompass Health.

Encompass Health (NYSE:EHC) last announced its earnings results on Tuesday, April 27th. The company reported $1.05 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.80 by $0.25. Encompass Health had a net margin of 5.76% and a return on equity of 15.52%. The company had revenue of $1.23 billion for the quarter, compared to analysts’ expectations of $1.23 billion.

Several research firms recently issued reports on EHC. Credit Suisse Group reduced their price target on shares of Encompass Health from $97.00 to $92.00 and set an “outperform” rating on the stock in a research report on Thursday, January 28th. Raymond James increased their price target on shares of Encompass Health from $90.00 to $95.00 and gave the stock an “outperform” rating in a research report on Thursday, April 29th.

Shares of EHC traded down $1.53 during mid-day trading on Friday, hitting $86.36. 704,612 shares of the company’s stock were exchanged, compared to its average volume of 637,637. Encompass Health has a 52 week low of $58.99 and a 52 week high of $89.68. The stock’s 50-day simple moving average is $84.27 and its 200-day simple moving average is $80.81. The firm has a market cap of $8.60 billion, a price-to-earnings ratio of 32.34, a price-to-earnings-growth ratio of 9.32 and a beta of 1.10. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 1.87.

The company also recently declared a quarterly dividend, which will be paid on Thursday, July 15th. Investors of record on Thursday, July 1st will be given a dividend of $0.28 per share. The ex-dividend date is Wednesday, June 30th. This represents a $1.12 annualized dividend and a dividend yield of 1.30%. Encompass Health’s dividend payout ratio is 28.64%.

About Encompass Health

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Recommended Story: Resistance Level

Get a free copy of the Zacks research report on Encompass Health (EHC)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with's FREE daily email newsletter.